Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
R. Palmér (Gothenburg, Sweden), J. Almquist (Gothenburg, Sweden), M. Hashemi (Gothenburg, Sweden), Z. Taib (Gothenburg, Sweden), S. Necander (Gothenburg, Sweden), K. Korsback (Gothenburg, Sweden), M. Aurell (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), S. Delaney (Gothenburg, Sweden), K. Pardali (Gothenburg, Sweden), P. Gustafson (Gothenburg, Sweden), T. Sethi (Gothenburg, Sweden), D. Keeling (Gothenburg, Sweden), I. Psallidas (Gothenburg, Sweden)
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Palmér (Gothenburg, Sweden), J. Almquist (Gothenburg, Sweden), M. Hashemi (Gothenburg, Sweden), Z. Taib (Gothenburg, Sweden), S. Necander (Gothenburg, Sweden), K. Korsback (Gothenburg, Sweden), M. Aurell (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), S. Delaney (Gothenburg, Sweden), K. Pardali (Gothenburg, Sweden), P. Gustafson (Gothenburg, Sweden), T. Sethi (Gothenburg, Sweden), D. Keeling (Gothenburg, Sweden), I. Psallidas (Gothenburg, Sweden). Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis. 2278
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: